Skip to Main Content

Author Details

Thomas Str??mberg
Uppsala University
1993
17
15
PMIDPaper TitleJournal TitlePublished Year
26021470Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells.Med Oncol2015
26021470Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells.Med Oncol2015
25268741Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via insulin-like growth factor-1 receptor-independent mechanism.Oncotarget2014
25268741Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via insulin-like growth factor-1 receptor-independent mechanism.Oncotarget2014
22159423Multiple antitumor effects of picropodophyllin in colon carcinoma cell lines: clinical implications.Int J Oncol2012
22159423Multiple antitumor effects of picropodophyllin in colon carcinoma cell lines: clinical implications.Int J Oncol2012
21147068Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9.Biochem Biophys Res Commun2011
21147068Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9.Biochem Biophys Res Commun2011
20150364Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma.Neuro Oncol2010
20150364Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma.Neuro Oncol2010
18369103Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia.Science2008
18800051Sex chromosome anomalies in childhood onset schizophrenia: an update.Mol Psychiatry2008
18369103Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia.Science2008
18800051Sex chromosome anomalies in childhood onset schizophrenia: an update.Mol Psychiatry2008
16046527Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model.Blood2006
16046527Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model.Blood2006
16166596IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells.Blood2006
16763011Segmental uniparental isodisomy on 5q32-qter in a patient with childhood-onset schizophrenia.J Med Genet2006
16763011Segmental uniparental isodisomy on 5q32-qter in a patient with childhood-onset schizophrenia.J Med Genet2006
16166596IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells.Blood2006
15860671Ectopic and IFN-induced expression of Fas overcomes resistance to Fas-mediated apoptosis in multiple myeloma cells.Blood2005
15860671Ectopic and IFN-induced expression of Fas overcomes resistance to Fas-mediated apoptosis in multiple myeloma cells.Blood2005
15070696Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone.Blood2004
15070696Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone.Blood2004
12529679Expression and function of chemokine receptors in human multiple myeloma.Leukemia2003
12529679Expression and function of chemokine receptors in human multiple myeloma.Leukemia2003
12366710Expression of the bcl-2 family of pro- and anti-apoptotic genes in multiple myeloma and normal plasma cells: regulation during interleukin-6(IL-6)-induced growth and survival.Eur J Haematol2002
12366710Expression of the bcl-2 family of pro- and anti-apoptotic genes in multiple myeloma and normal plasma cells: regulation during interleukin-6(IL-6)-induced growth and survival.Eur J Haematol2002
11676398Multiple myeloma cells are killed by syndecan-1-directed superantigen-activated T cells.Cancer Immunol Immunother2001
11676398Multiple myeloma cells are killed by syndecan-1-directed superantigen-activated T cells.Cancer Immunol Immunother2001
10029602The somatostatin analog octreotide inhibits growth of interleukin-6 (IL-6)-dependent and IL-6-independent human multiple myeloma cell lines.Blood1999
10029602The somatostatin analog octreotide inhibits growth of interleukin-6 (IL-6)-dependent and IL-6-independent human multiple myeloma cell lines.Blood1999
8239657Assembly of Atlantic cod (Gadus morhua) brain microtubules at different temperatures: dependency of microtubule-associated proteins is relative to temperature.Arch Biochem Biophys1993
8239657Assembly of Atlantic cod (Gadus morhua) brain microtubules at different temperatures: dependency of microtubule-associated proteins is relative to temperature.Arch Biochem Biophys1993
  • 1 - 34 of 34

Recommended Authors

university of california san diego Department of Pediatrics, University of California
Career Start Year 2007
Number of shared co-authors 0
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2000
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 2
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
Parker Institute for Cancer Immunotherapy
Career Start Year 1996
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1996
Number of shared co-authors 0
Thomas Jefferson University Hospital
Career Start Year 1994
Number of shared co-authors 0
Oncology R&D
Career Start Year 1992
Number of shared co-authors 0
Oncology Research Unit, Inc.
Career Start Year 1991
Number of shared co-authors 0
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 1
Hospital del Mar Research Institute
Career Start Year 1990
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1990
Number of shared co-authors 0
Winship Cancer Institute, Emory University
Career Start Year 1988
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 0
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 0
Johns Hopkins School of Medicine
Career Start Year 1986
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1985
Number of shared co-authors 0
Universite Cote d'Azur, INSERM U5
Career Start Year 1982
Number of shared co-authors 0
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 2
Dana Farber Cancer Institute
Career Start Year 1981
Number of shared co-authors 0
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 0
National Cancer Institute
Career Start Year 1978
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1977
Number of shared co-authors 2
Osteosarcoma Institute
Career Start Year 1977
Number of shared co-authors 2
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1975
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 0
The University of Texas Health Science Center at San Antonio
Career Start Year 1971
Number of shared co-authors 1

Collaborators

Co-authored papers 3
David Geffen School of Medicine, University of California los angeles
Co-authored papers 3
National Institute of Mental Health, National Institutes of Health
Co-authored papers 3
National Institute of Mental Health in Bethesda
Co-authored papers 3
university of california los angeles
Co-authored papers 3
National Institute of Mental Health, National Institutes of Health
Co-authored papers 3
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
University of Pittsburgh
Co-authored papers 2
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
San Francisco Veterans Affairs Medical Center
Co-authored papers 2
Co-authored papers 1
SUNY College at Old Westbury
Co-authored papers 1
National Institute on Aging
Co-authored papers 1
University of Washington
Co-authored papers 1
MS Research Unit
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Co-authored papers 1
Virginia Commonwealth University
Co-authored papers 1
University of Washington
Co-authored papers 1
Wellcome Sanger Institute
Co-authored papers 1
University of Washington
Co-authored papers 1
Clinic for Cattle, University of Veterinary Medicine Hannover
Co-authored papers 1
Duke University
Co-authored papers 1
UC Davis Center for Neuroscience.
Co-authored papers 1
Co-authored papers 1
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
University of Washington
Co-authored papers 1
HudsonAlpha Institute for Biotechnology
Co-authored papers 1
B.P. Koirala Institute of Health Sciences
Co-authored papers 1